Cambridge Investment Research Advisors’s Innovator Equity Defined Protection ETF - 6mo Apr/Oct APOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.77M Sell
69,502
-1,793
-3% -$47K ﹤0.01% 1681
2025
Q4
$1.87M Sell
71,295
-70,052
-50% -$1.82M ﹤0.01% 1593
2025
Q3
$3.66M Buy
141,347
+199
+0.1% +$5.12K 0.01% 1091
2025
Q2
$3.6M Sell
141,148
-12,219
-8% -$308K 0.01% 1045
2025
Q1
$3.85M Sell
153,367
-184,534
-55% -$4.71M 0.01% 938
2024
Q4
$8.61M Buy
+337,901
New +$8.58M 0.03% 548

Other funds holding APOC

Cambridge Investment Research Advisors's APOC Position: Q1 2026 in Review

Cambridge Investment Research Advisors reduced its Innovator Equity Defined Protection ETF - 6mo Apr/Oct (APOC) stake by 2.5% in Q1 2026, selling an estimated $47K and leaving 69,502 shares worth $1.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1681.

Cambridge Investment Research Advisors first reported a position in APOC in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.61M in Q4 2024. 58 funds tracked by Wall St. Rank hold APOC as of Q1 2026.

  • Cambridge Investment Research Advisors held 69,502 shares of Innovator Equity Defined Protection ETF - 6mo Apr/Oct worth $1.77M as of Q1 2026.
  • Cambridge Investment Research Advisors sold 1,793 Innovator Equity Defined Protection ETF - 6mo Apr/Oct shares in Q1 2026, an estimated $47K.
  • Innovator Equity Defined Protection ETF - 6mo Apr/Oct made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #1681 holding.
  • Cambridge Investment Research Advisors first reported a position in Innovator Equity Defined Protection ETF - 6mo Apr/Oct in Q4 2024 and has held it in 6 quarters since.
  • Cambridge Investment Research Advisors's Innovator Equity Defined Protection ETF - 6mo Apr/Oct position peaked at $8.61M in Q4 2024.
  • 58 funds tracked by Wall St. Rank held Innovator Equity Defined Protection ETF - 6mo Apr/Oct as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.